Biotech Values

[jq1234]

Yes, N=46 and N=37 for figure 6A, but per footnote: Censoring rates: docetaxel-naïve 85%; docetaxel-pretreated 78%, so very few patients left non-censored.

6B, N=14 and N=17, but Censoring rates: cabozantinib 79%; placebo 29%.

Overall, only placebo group is reasonablely representative of eventual result, the other 3 groups could be highly distorted at this point.